ZEB2 and breast carcinoma: However, we found this inverse association between ZEB2 and miR-200b-3p (Figure 4J, r = −0.406, p = 0.05) when the whole cohort of breast cancer patients was combined as one group regardless of IBC and non-IBC subtyping.